Clene (CLNN) Debt Ratio (2019 - 2026)
Clene (CLNN) posted Debt Ratio of 0.25 for Q2 2026, down 41.73% on a QoQ basis from 0.43 in Q4 2025, and up 11.29% year-over-year from 0.23 in Q2 2025.
Analysis
Clene (CLNN) Debt Ratio (2019 - 2026) Analysis & Trends
Clene has reported Debt Ratio for 8 years, with the latest figure at 0.25 in Q2 2026.
- On a quarterly basis, Debt Ratio rose 11.29% year-over-year to 0.25 in Q2 2026; TTM through Jun 2026 was 0.25, a 11.29% increase from a year earlier, with the FY2025 full-year figure at 0.43, up 137.13% from the prior year.
- Debt Ratio was 0.25 for Q2 2026 at Clene, down from 0.43 in the prior quarter.
- The five-year high for Debt Ratio was 0.55 in Q2 2024, with the low at 0.18 in Q4 2024.
- Average Debt Ratio over 5 years is 0.34, with a median of 0.35 recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Debt Ratio soared 775.13% in 2022, then tumbled 59.0% in 2025.
- Over 5 years, Debt Ratio stood at 0.36 in 2022, then gained by 14.39% to 0.41 in 2023, then tumbled by 55.54% to 0.18 in 2024, then soared by 137.13% to 0.43 in 2025, then plunged by 41.73% to 0.25 in 2026.
- The last three Debt Ratio figures came in at 0.25 (Q2 2026), 0.43 (Q4 2025), and 0.26 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 0.30 |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 0.08 |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 0.17 |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 0.00 |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | 0.25 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.25 |
| Dec 31, 2025 | 0.43 |
| Sep 30, 2025 | 0.26 |
| Jun 30, 2025 | 0.23 |
| Mar 31, 2025 | 0.20 |
| Dec 31, 2024 | 0.18 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | 0.55 |
| Mar 31, 2024 | 0.48 |
| Dec 31, 2023 | 0.41 |
| Sep 30, 2023 | 0.27 |
| Jun 30, 2023 | 0.24 |
| Mar 31, 2023 | 0.41 |
| Dec 31, 2022 | 0.36 |
| Sep 30, 2022 | 0.44 |
| Jun 30, 2022 | 0.35 |
| Mar 31, 2022 | 0.28 |
| Dec 31, 2021 | 0.23 |
| Sep 30, 2021 | 0.20 |
| Jun 30, 2021 | 0.14 |